General objective of the capacity building: The primary objective of the study was to understand the efficacy of rapid regimen of HBV vaccination with standard dosing among PLHIV and PWID, promote as a replicable model and advocate for high-risk groups.
Results show that the 21-day rapid vaccination regimen with standard dose is feasible in PWID and PLHIV, easy to comply with and can lead to high rates of protection against HBV. Broader use of this approach would prevent unvaccinated adults from acquiring new infections and lead to better control of hepatitis B in the community. Larger studies are needed to optimize strategies to scale up use of the rapid regimen.
Sample: 372 IDU
